Characterizaton and Validation 2023

The current viral vector characterization landscape: from navigating evolving regulatory guidance to leveraging analytical tools for process development

Cell & Gene Therapy Insights 2023; 9(11), 1503–1509

DOI: 10.18609/cgti.2023.197

Published: 8 December 2023
Ning Ding

“Peering into the future a decade from now, there is an expectation of significant regulatory evolution in the realm of viral vector development, foreseeing the development of evolving guidelines and increased flexibility in response to emerging technologies and novel therapeutic approaches.”